These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 334981)

  • 1. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
    Klassen LW; Zarate A; Gelfand MC; Steinberg AD
    J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of allograft survival in mice by administration of anti-Thy 1 serum. I. Mediation by in vivo activation of regulatory T cells.
    Gelfand MC; Paul WE
    J Immunol; 1975 Jul; 115(1):1-4. PubMed ID: 1097498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective loss of suppressor cell function in New Zealand mice induced by NTA.
    Klassen LW; Krakauer RS; Steinberg AD
    J Immunol; 1977 Sep; 119(3):830. PubMed ID: 19534
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immunity and aging.
    Stutman O
    Fed Proc; 1974 Sep; 33(9):2028-32. PubMed ID: 4153574
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT; Röllinghoff M; Warner NL
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo induction of suppressor activity with rabbit antimouse thymocyte serum (ATS) and antigen.
    Simpson M; Tuttle S; Gozzo JJ
    Transplant Proc; 1977 Mar; 9(1):1041-4. PubMed ID: 325731
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on heterologous antilymphocyte and antithymocyte sera. V. Loss or retention of immunosuppressive activity after absorption with sheep erythrocytes.
    Barth RF; Singla O
    J Immunol; 1972 Nov; 109(5):1003-8. PubMed ID: 4562422
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive effects of anti-lymphocyte serum in complement deficient mice. II. Evidence that activity is mediated by C3 independent antibodies.
    Barth RF; Singla O; Ward PA
    J Immunol; 1974 Feb; 112(2):858-61. PubMed ID: 4205210
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells.
    Theofilopoulos AN; Shawler DL; Katz DH; Dixon FJ
    J Immunol; 1979 Jun; 122(6):2319-27. PubMed ID: 36433
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of allograft rejection in New Zealand mice. II. Role of a serum factor.
    Gelfand MC; Parker LM; Steinberg AD
    J Immunol; 1974 Jul; 113(1):1-8. PubMed ID: 4598887
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfer of cell-mediated hyperacute rejection reaction. The role of active sensitization.
    Emam M; Barstad R; Eichwald EJ
    Cell Immunol; 1980 Feb; 49(2):426-31. PubMed ID: 6986205
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible manipulations of allograft tolerance by suppressor cells.
    Hilgert I; Rieger M; Kristofová H; Vlachov K; Singh SK
    Transplant Proc; 1979 Mar; 11(1):887-90. PubMed ID: 88103
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerance and suppressor T cells.
    Brent L
    Proc Eur Dial Transplant Assoc; 1977; 14():245-50. PubMed ID: 341124
    [No Abstract]   [Full Text] [Related]  

  • 15. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
    Wood ML; Monaco AP
    Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
    [No Abstract]   [Full Text] [Related]  

  • 16. T cell-derived factor alone or in combination with immunosuppressive drugs augments prolongation of allogeneic skin graft survival in mice receiving donor-specific transfusion.
    Gorczynski RM; Boulanger M; Lau C
    J Immunol; 1987 May; 138(10):3197-202. PubMed ID: 2952712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 18. Facilitation of metastasis by antithymocyte globulin.
    James SE; Salsbury AJ
    Cancer Res; 1974 Feb; 34(2):367-70. PubMed ID: 4544019
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY; Hale C; Howard JG
    J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.